TG-100435
Product Specifications
CAS Number
867330-68-5
Target
Ephrin Receptor, Bcr-Abl, Src
Related Pathways
Cytoskeletal Signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
TG-100435 is a novel multi-target oral protein tyrosine kinase inhibitor. The metabolic flux of TG100435 is entirely inhibited by methimazole and ketoconazole. In human liver microsomes or recombinant P450, the formation of TG100435 increases with the activity of cytochrome P450 reductase, suggesting that cytochrome P450 reductase may be involved.
Smiles
ClC=1C=CC=C(Cl)C1C2=CC=3N=NC(=NC3C(=C2)C)NC4=CC=C(OCCN5CCCC5)C=C4
Molecular Formula
C26H25Cl2N5O
Molecular Weight
494.42
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6270214-01 0.1 mL
WAVE2, Phosphorylated (Ser343) (Wiskott-Aldrich Syndrome Protein Family Member 2, WASP Family Protein Member 2, Protein WAVE-2, Verprolin Homology Domain-containing Protein 2, WASF2) (HRP)
Sign In for Pricing
View Details 
MBS6270214-02 5x 0.1 mL
WAVE2, Phosphorylated (Ser343) (Wiskott-Aldrich Syndrome Protein Family Member 2, WASP Family Protein Member 2, Protein WAVE-2, Verprolin Homology Domain-containing Protein 2, WASF2) (HRP)
Sign In for Pricing
View Details K0076607 1.0 µg DNA
ALOXE3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
